Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Greg J. Ahmann"'
Autor:
Yuan Xiao Zhu, Laura A. Bruins, Xianfeng Chen, Chang‐Xin Shi, Cecilia Bonolo De Campos, Nathalie Meurice, Xuewei Wang, Greg J. Ahmann, Colleen A. Ramsower, Esteban Braggio, Lisa M. Rimsza, A. Keith Stewart
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 804-814 (2022)
Abstract Identifying biomarkers associated with disease progression and drug resistance are important for personalized care. We investigated the expression of 121 curated genes, related to immunomodulatory drugs (IMiDs) and proteasome inhibitors (PIs
Externí odkaz:
https://doaj.org/article/8f3eb729be1e4a28ae8d99d742fc9bbd
Autor:
Mariano Arribas, Esteban Braggio, Rafael Fonseca, Elitza S. Theel, Greg J. Ahmann, Skye A. Buckner Petty
Publikováno v:
American journal of hematology. 97(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3de2c8035be306ecfb8600abde8107
https://pubmed.ncbi.nlm.nih.gov/34822201
https://pubmed.ncbi.nlm.nih.gov/34822201
Autor:
Shaji Kumar, Alysia N. Polito, David Dingli, Esteban Braggio, Nathalie Meurice, Kimberly J. Henderson, Jeremy T. Larsen, P. Leif Bergsagel, Joachim L. Petit, Ilsel D Lopez Armenta, Susie A. Darvish, Greg J. Ahmann, Yuan Xiao Zhu, Craig B. Reeder, Prashant Kapoor, Rafael Fonseca, William Stewart, Xuewei Wang, Jonas J. Kruse, Laura Ann Bruins, A. Keith Stewart, Shulan Tian, Cecília Bonolo de Campos, Panwen Wang
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-16 (2020)
Blood Cancer Journal, Vol 10, Iss 5, Pp 1-16 (2020)
Seventy-six FDA-approved oncology drugs and emerging therapeutics were evaluated in 25 multiple myeloma (MM) and 15 non-Hodgkin’s lymphoma cell lines and in 113 primary MM samples. Ex vivo drug sensitivities were mined for associations with clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216f8e0dfaa638d56d14f713e82745aa
http://europepmc.org/articles/PMC7214452
http://europepmc.org/articles/PMC7214452
Autor:
Rafael Fonseca, Sinto Sebastian, Luke Mountjoy, Greg J. Ahmann, Miguel Gonzalez-Velez, Tania Jain, Jeremy T. Larsen, Leif Bergsagel, Marlene Girardo, Talal Hilal
Publikováno v:
Leukemia. 34(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d52dcf6de8aa5453d813404ecc6b7d6
https://pubmed.ncbi.nlm.nih.gov/32503975
https://pubmed.ncbi.nlm.nih.gov/32503975
Autor:
A. Keith Stewart, Scott Van Wier, Chang Xin Shi, P. Leif Bergsagel, Sonali Panchabhai, Yuan X. Zhu, Marta Chesi, Sinto Sebastian, Rafael Fonseca, Esteban Braggio, Greg J. Ahmann
Publikováno v:
Blood. 129:991-1007
Lenalidomide is an immunomodulatory drug (IMiDs) with clinical efficacy in multiple myeloma (MM) and other late B-cell neoplasms. Although cereblon (CRBN) is an essential requirement for IMiD action, the complete molecular and biochemical mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2184b4da0431c9de7cb7a6733696ffd2
https://doi.org/10.1182/blood-2016-09-738872
https://doi.org/10.1182/blood-2016-09-738872
Autor:
Daniel L. Riggs, Caleb K. Stein, A. Keith Stewart, K. Martin Kortüm, Shaji Kumar, Yan W. Asmann, Robert A. Kyle, P. Leif Bergsagel, Grady Day, Jonathan J Keats, Greg J. Ahmann, Niamh Keane, S. Vincent Rajkumar, David S. Viswanatha, Marta Chesi, Scott Van Wier, Kristine Misund, Angela Dispenzieri, Verónica González-Calle, Esteban Braggio, Michael O'Dwyer, Seth J. Welsh, Rafael Fonseca, W. Michael Kuehl
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b4258c806d6f2400ce1ac6bd447ede
http://hdl.handle.net/11250/2641175
http://hdl.handle.net/11250/2641175
Autor:
Betsy LaPlant, Martha Q. Lacy, Joseph R. Mikhael, A. Keith Stewart, P. Leif Bergsagel, Chang Xin Shi, Kristina Laumann, Shaji Kumar, Steven R. Schuster, S. Vincent Rajkumar, Jessica Schmidt, Greg J. Ahmann, Laura Ann Bruins, Mia D. Champion, Bart Barlogie, Rafael Fonseca, K. Martin Kortuem, Esteban Braggio, Yuan Xiao Zhu
Publikováno v:
Leukemia Research. 38:23-28
Cereblon (CRBN) mediates immunomodulatory drug (IMiD) action in multiple myeloma (MM). We demonstrate here that no patient with very low CRBN expression responded to IMiD plus dexamethasone therapy. In 53 refractory MM patients treated with pomalidom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a33a1727a88199d7f7b52b2c055569
https://doi.org/10.1016/j.leukres.2013.08.015
https://doi.org/10.1016/j.leukres.2013.08.015
Autor:
Alysia N. Polito, Laura Ann Bruins, Nathalie Meurice, Xuewei Wang, Joachim L. Petit, Chang-Xin Shi, Esteban Braggio, Keith Stewart, Cecília Bonolo de Campos, Greg J. Ahmann, Yuan Xiao Zhu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f8cc572e75ed5d91f92f2b54f1440b6
https://doi.org/10.1016/j.clml.2019.09.189
https://doi.org/10.1016/j.clml.2019.09.189
Autor:
Rafael Fonseca, Gerardo Colon-Otero, Matthew S. Jorgensen, Prakash Vishnu, Scott Van Wier, James M. Foran, James R. Cerhan, Monica Albertie, Colleen S. Thomas, Esteban Braggio, Sikander Ailawadhi, Greg J. Ahmann, Jennifer A. Weis
The translocation t(14;18)(q32;q21) (BCL-2/J(H)) is present in over 80 % of all follicular lymphomas and is detectable in peripheral blood lymphocytes (PBL) of healthy individuals. The prevalence of this translocation has not been studied in African
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8def84e1225f4e1d63b7a26b560e1efd
https://europepmc.org/articles/PMC5203940/
https://europepmc.org/articles/PMC5203940/
Autor:
Sinto, Sebastian, Yuan X, Zhu, Esteban, Braggio, Chang-Xin, Shi, Sonali C, Panchabhai, Scott A, Van Wier, Greg J, Ahmann, Marta, Chesi, P Leif, Bergsagel, A Keith, Stewart, Rafael, Fonseca
Publikováno v:
Blood. 129(8)
Lenalidomide is an immunomodulatory drug (IMiDs) with clinical efficacy in multiple myeloma (MM) and other late B-cell neoplasms. Although cereblon (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a78527794d1f3bf0f2036a2b84ed07f4
https://pubmed.ncbi.nlm.nih.gov/28232622
https://pubmed.ncbi.nlm.nih.gov/28232622